Today, 54gene announced the launch of its Clinical Program Services (CPS) division. The CPS division is focused on partnering with global pharmaceutical and biotechnology companies, and multilateral health organizations to discover, develop, and commercialize new therapeutic and diagnostic products.
54gene, named after the 54 countries in Africa, was started in 2019 by founder and CEO, Abasi Ene-Obong, PhD. It is a U.S.- and Nigerian-based health technology company, whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics, and clinical programs.
